Industry reports
Editor highlights

Pharmaceutical Analysis & Statistics, April 2014

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1-30 of about 100 reports
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics

Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics

  • $ 264
  • Industry report
  • January 2014
  • by La Merie Publishing

Novel Prophylactic and Therapeutic Approaches to Manage and Prevent Clostridium difficile Infections (CDI) Clostridium difficile infections (CDI) are a major public health concern.  CDI are becoming ...

  • Industries : Drug and Medication
Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors

  • $ 528
  • Industry report
  • November 2013
  • by La Merie Publishing

Develpment update for new JAK and syk Inhibitors This Competitive Intelligence Report about new developments in the pipeline of inhibitors of the janus-associated kinase (JAK) and of spleen tyrosine ...

  • Industries : Pathology
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)

  • $ 660
  • Industry report
  • October 2013
  • by La Merie Publishing

Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections Staphylococcus aureus disease is the leading cause of surgical site infections and infections that ...

  • Industries : Drug and Medication
Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors Product description Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid ...

  • Industries : Drug Delivery Technology
Competitor Analysis: Pim Kinase Inhibitors

Competitor Analysis: Pim Kinase Inhibitors

  • $ 132
  • Industry report
  • September 2013
  • by La Merie Publishing

Competitor Analysis: Pim Kinase Inhibitors Product description The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cance ...

  • Industries : Therapy
Competitor Analysis: Bruton's Tyrosine Kinase (BTK) Inhibitors

Competitor Analysis: Bruton's Tyrosine Kinase (BTK) Inhibitors

  • $ 132
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Bruton Tyrosine Kinase (BTK) Inhibitors Product description The present Competitive Intelligence report about Bruton's Tyrosine Kinase (BTK) Inhibitors provides a competito ...

  • Industries : Pathology
Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors

  • $ 198
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors Product description The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competito ...

  • Industries : Pathology
Competitor Analysis: Smallpox Vaccines & Therapeutics

Competitor Analysis: Smallpox Vaccines & Therapeutics

  • $ 198
  • Industry report
  • August 2013
  • by La Merie Publishing

Competitor Analysis: Smallpox Vaccines & Therapeutics Product description The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis in ...

  • Industries : Drug and Medication
Competitor Analysis: Anthrax Vaccines & Therapeutics

Competitor Analysis: Anthrax Vaccines & Therapeutics

  • $ 264
  • Industry report
  • June 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics fo ...

  • Industries : Drug and Medication
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • $ 330
  • Industry report
  • May 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines ...

  • Industries : Drug and Medication
Competitor Analysis: Interferon

Competitor Analysis: Interferon

  • $ 594
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural interferon ...

  • Industries : Drug and Medication
Competitor Analysis: Insulin

Competitor Analysis: Insulin

  • $ 594
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report Insulin as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant insulin and insulin ...

  • Industries : Pathology
  • Countries : India, China
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

  • $ 330
  • Industry report
  • February 2013
  • by La Merie Publishing

Product description The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development ...

  • Industries : Therapy
Competitor Analysis: Herpes Virus Vaccines and Therapeutics

Competitor Analysis: Herpes Virus Vaccines and Therapeutics

  • $ 396
  • Industry report
  • December 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Herpes Virus Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies ...

  • Industries : Drug and Medication
Competitor Analysis: Pneumococcal and Streptococcal Vaccines

Competitor Analysis: Pneumococcal and Streptococcal Vaccines

  • $ 264
  • Industry report
  • October 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Pneumococcla and Streptococcal Vaccines provides a competitor evaluation in the field of prophylactic vaccines against infection caused by streptococcus ...

  • Industries : Drug and Medication
Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Competitor Analysis: Tuberculosis Vaccines and Therapeutics

  • $ 528
  • Industry report
  • September 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Tuberculosis Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic small molecules ...

  • Industries : Drug and Medication
Competitor Analysis: CMV Vaccines & Therapeutics

Competitor Analysis: CMV Vaccines & Therapeutics

  • $ 264
  • Industry report
  • August 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about CMV Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, antisense, ...

  • Industries : Drug and Medication
Competitor Analysis: Malaria Vaccines & Therapeutics

Competitor Analysis: Malaria Vaccines & Therapeutics

  • $ 396
  • Industry report
  • August 2012
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and biologics to treat ...

  • Industries : Drug and Medication
Competitor Analysis: Dengue Virus Vaccines and Therapeutics

Competitor Analysis: Dengue Virus Vaccines and Therapeutics

  • $ 264
  • Industry report
  • July 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Dengue Virus Vaccines & Therapeutics provides a competitor evaluation in the field of investigational vaccines and therapeutics against one or more serotypes ...

  • Industries : Drug and Medication
Competitor Analysis: RSV Vaccines and Therapeutics

Competitor Analysis: RSV Vaccines and Therapeutics

  • $ 330
  • Industry report
  • June 2012
  • by La Merie Publishing

Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a competitor evaluation in the ...

  • Industries : Drug and Medication
  • Countries : United States
Competitor Analysis: Pseudomonas aeruginosa Vaccines and Therapeutics

Competitor Analysis: Pseudomonas aeruginosa Vaccines and Therapeutics

  • $ 396
  • Industry report
  • May 2012
  • by La Merie Publishing

The present Competitive Intelligence Report about Pseudomonas aeruginosa Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, peptides ...

  • Industries : Therapy
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics

Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics

  • $ 396
  • Industry report
  • May 2012
  • by La Merie Publishing

Summary The present Competitive Intelligence Report about prophylaxis and therapy of S. aureus infections provides a competitor evaluation in the field of molecules for prevention or treatment of Staphylococcus ...

  • Industries : Drug and Medication
Competitor Analysis: Enzyme Replacement Therapies

Competitor Analysis: Enzyme Replacement Therapies

  • $ 396
  • Industry report
  • January 2012
  • by La Merie Publishing

Product description The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement ...

  • Industries : Pathology
Competitor Analysis: HIV Small Molecule Therapeutics

Competitor Analysis: HIV Small Molecule Therapeutics

  • $ 660
  • Industry report
  • December 2011
  • by La Merie Publishing

Competitior Analysis: HIV Small Molecule Therapeutics The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides ...

  • Industries : Therapy
  Competitor Analysis: Anti-Infective Peptides

  Competitor Analysis: Anti-Infective Peptides

  • $ 396
  • Industry report
  • November 2011
  • by La Merie Publishing

Product Description The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects ...

  • Industries : Drug and Medication
 Competitor Analysis Cancer Vaccines

 Competitor Analysis Cancer Vaccines

  • $ 924
  • Industry report
  • November 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against cancer. Purchase ...

  • Industries : Drug and Medication
 Competitor Analysis: Cardiovascular Peptides

 Competitor Analysis: Cardiovascular Peptides

  • $ 396
  • Industry report
  • November 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, arrhythmias, hypertension, peripheral ...

  • Industries : Pathology
Competitor Analysis: Anti-Infective Antibodies

Competitor Analysis: Anti-Infective Antibodies

  • $ 1 056
  • Industry report
  • November 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human ...

  • Industries : Drug and Medication
Competitor Analysis HIV Vaccines

Competitor Analysis HIV Vaccines

  • $ 396
  • Industry report
  • October 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence report about HIV Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against human immunodeficiency ...

  • Industries : Drug and Medication
Vaccine Pipeline Database: 1-Year Subscription

Vaccine Pipeline Database: 1-Year Subscription

  • $ 1 320
  • Industry report
  • October 2011
  • by La Merie Publishing

Product description Subscription to La Merie's proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and ...

  • Industries : Drug and Medication

» Read our Company Profiles

3 Companies

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.